WELD CAPITAL MANAGEMENT LLC - PROGENICS PHARMACEUTICALS IN ownership

PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 137 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELD CAPITAL MANAGEMENT LLC ownership history of PROGENICS PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2019$80,00013,0170.02%
Other shareholders

There were no reported owners of PROGENICS PHARMACEUTICALS IN in Q3 2019.

NameSharesValueWeighting ↓
View complete list of PROGENICS PHARMACEUTICALS IN shareholders